Awareness, Willingness, and Uptake of Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men in Ghana

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2025 Feb 13

PMID 39948458

Authors

Amos Apreku

Chris Guure

Samuel Dery

Alhassan Yakubu

Gamji Rabiu Abu-Baare

Stephen Ayisi Addo

Kwasi Torpey

Affiliations

Soon will be listed here.

Abstract

Background: HIV prevalence among men who have sex with men (MSM) in Ghana is 18.1% as compared to 1.6% in the general population. Pre-exposure Prophylaxis (PrEP) is recommended by the World Health Organization (WHO) for people who are HIV-negative and at high risk of acquiring HIV. Since PrEP introduction in Ghana in 2020, little is known nationally about the level of awareness, uptake, and willingness to take PrEP among MSM. This study aims to generate estimates on PrEP awareness, uptake and willingness to use among MSM in Ghana.

Methods: We conducted a bio-behavioral survey among MSM aged 18 years and above in all the 10 traditional regions in Ghana from August 2022 to July 2023 using respondent-driven sampling (RDS). RDS-Analyst was used to compute weights based on the participants' network. Data analysis was restricted to MSM who were HIV-negative and sexually active to estimate the prevalence of awareness, willingness, and uptake of PrEP. A multivariable logistic regression model was used to assess the factors influencing these outcomes.

Results: Out of the 3,420 total MSM surveyed, 2,627 were HIV negative and were included in the analysis, Out of which 44.5% (95% CI: 42.0-47.0) were aware of PrEP, 90.4% (95% CI: 88.0-92.3) were willing to take PrEP and 17.8% (95% CI: 16.0 - 19.8) had ever taken PrEP. In the regression analyses, PrEP awareness was 5-fold higher among those who completed tertiary education (aOR: 5.56, 95% CI: 2.87-10.78, p < 0.001) and 4-fold among those who interacted with peer educators (aOR: 3.78, 95% CI: 2.52-5.67, p < 0.001). In terms of uptake, the odds were almost 9 times among those who had experienced forced sex (aOR: 8.88, 95% CI: 1.42-55.47, p = 0.02). MSM aged 25-34 were less willing to take PrEP (aOR:0.21, 95% CI 0.07-0.65, p = 0.006) and PrEP use was also less likely among those who consumed high alcohol (aOR:0.42, 95% CI 0.19-0.92, p = 0.03) and never tested for HIV (aOR: 0.44, 95% CI" 0.25-0.88, p = 0.017).

Conclusion: In Ghana, awareness and willingness to take PrEP to prevent HIV is high, but uptake is low. These results highlight the need for interventions to improve the overall uptake of PrEP among MSM in Ghana, especially among those aged 25-34, high alcohol consumers and those who have never screened for HV. Effective implementation of these findings into the national policies can enhance access and encourage PrEP use, ultimately reducing HIV incidence in Ghana among MSM.

References

Guure C, Dery S, Afagbedzi S, Maya E, Da-Costa Vroom F, Torpey K . Correlates of prevalent HIV infection among adolescents, young adults, and older adult female sex workers in Ghana: Analysis of data from the Ghana biobehavioral survey. PLoS One. 2023; 18(11):e0292686. PMC: 10655993. DOI: 10.1371/journal.pone.0292686. View

Liu Y, Hawkins M, Osman A, Zhang C . Assessing the Prevalence and Determinants of Exposure-Influenced HIV Testing among a Sample of Pre- and Post-Exposure Prophylaxis-Naïve Young Men Who Have Sex with Men in the United States. Trop Med Infect Dis. 2022; 7(8). PMC: 9331231. DOI: 10.3390/tropicalmed7080146. View

Kamitani E, Wichser M, Mizuno Y, DeLuca J, Higa D . What Factors Are Associated With Willingness to Use HIV Pre-exposure Prophylaxis (PrEP) Among U.S. Men Who Have Sex With Men Not on PrEP? A Systematic Review and Meta-analysis. J Assoc Nurses AIDS Care. 2022; 34(2):135-145. PMC: 10184317. DOI: 10.1097/JNC.0000000000000384. View

Landovitz R, Donnell D, Clement M, Hanscom B, Cottle L, Coelho L . Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. N Engl J Med. 2021; 385(7):595-608. PMC: 8448593. DOI: 10.1056/NEJMoa2101016. View

Ding Y, Yan H, Ning Z, Cai X, Yang Y, Pan R . Low willingness and actual uptake of pre-exposure prophylaxis for HIV-1 prevention among men who have sex with men in Shanghai, China. Biosci Trends. 2016; 10(2):113-9. DOI: 10.5582/bst.2016.01035. View

Brooks R, Landrian A, Lazalde G, Galvan F, Liu H, Chen Y . Predictors of Awareness, Accessibility and Acceptability of Pre-exposure Prophylaxis (PrEP) Among English- and Spanish-Speaking Latino Men Who have Sex with Men in Los Angeles, California. J Immigr Minor Health. 2019; 22(4):708-716. DOI: 10.1007/s10903-019-00955-w. View

Zigah E, Abu-Baare G, Shamrock O, Dakpui H, Apreku A, Boyd D . "For my safety and wellbeing, I always travel to seek health care in a distant facility"-the role of place and stigma in HIV testing decisions among GBMSM - BSGH 002. Health Place. 2023; 83:103076. DOI: 10.1016/j.healthplace.2023.103076. View

Hojilla J, Hurley L, Marcus J, Silverberg M, Skarbinski J, Satre D . Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System. JAMA Netw Open. 2021; 4(8):e2122692. PMC: 8391097. DOI: 10.1001/jamanetworkopen.2021.22692. View

Nelson L, Nyblade L, Torpey K, Logie C, Qian H, Manu A . Multi-level intersectional stigma reduction intervention to increase HIV testing among men who have sex with men in Ghana: Protocol for a cluster randomized controlled trial. PLoS One. 2021; 16(11):e0259324. PMC: 8629287. DOI: 10.1371/journal.pone.0259324. View

10.

Young I, McDaid L . How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2013; 18(2):195-216. PMC: 3905168. DOI: 10.1007/s10461-013-0560-7. View

11.

Wheelock A, Eisingerich A, Ananworanich J, Gomez G, Hallett T, Dybul M . Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance. PLoS One. 2013; 8(1):e54288. PMC: 3544831. DOI: 10.1371/journal.pone.0054288. View

12.

Ssekamatte T, Mugambe R, Nalugya A, Isunju J, Matovu J, Kansiime W . Predictors of consistent condom use among young psychoactive substance users in Kampala's informal settlements, Uganda. Dialogues Health. 2024; 1:100080. PMC: 10953897. DOI: 10.1016/j.dialog.2022.100080. View

13.

Yi S, Tuot S, Mwai G, Ngin C, Chhim K, Pal K . Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis. J Int AIDS Soc. 2017; 20(1):21580. PMC: 5515024. DOI: 10.7448/IAS.20.1.21580. View

14.

Mugo N, Ngure K, Kiragu M, Irungu E, Kilonzo N . The preexposure prophylaxis revolution; from clinical trials to programmatic implementation. Curr Opin HIV AIDS. 2015; 11(1):80-6. PMC: 4900687. DOI: 10.1097/COH.0000000000000224. View

15.

Schaefer R, Schmidt H, Ravasi G, Mozalevskis A, Rewari B, Lule F . Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study. Lancet HIV. 2021; 8(8):e502-e510. PMC: 8332196. DOI: 10.1016/S2352-3018(21)00127-2. View

16.

Wang Z, Mo P, Ip M, Fang Y, Lau J . Uptake and willingness to use PrEP among Chinese gay, bisexual and other men who have sex with men with experience of sexualized drug use in the past year. BMC Infect Dis. 2020; 20(1):299. PMC: 7178573. DOI: 10.1186/s12879-020-05024-4. View

17.

Guure C, Afagbedzi S, Torpey K . Willingness to take and ever use of pre-exposure prophylaxis among female sex workers in Ghana. Medicine (Baltimore). 2022; 101(5):e28798. PMC: 8812709. DOI: 10.1097/MD.0000000000028798. View

18.

Golub S, Fikslin R, Goldberg M, Pena S, Radix A . Predictors of PrEP Uptake Among Patients with Equivalent Access. AIDS Behav. 2019; 23(7):1917-1924. PMC: 6571035. DOI: 10.1007/s10461-018-2376-y. View

19.

Rugira E, Biracyaza E, Umubyeyi A . Uptake and Persistence on HIV Pre-Exposure Prophylaxis Among Female Sex Workers and Men Having Sex with Men in Kigali, Rwanda: A Retrospective Cross-Sectional Study Design. Patient Prefer Adherence. 2023; 17:2353-2364. PMC: 10542111. DOI: 10.2147/PPA.S427021. View

20.

Shamu S, Shamu P, Khupakonke S, Farirai T, Chidarikire T, Guloba G . Pre-exposure prophylaxis (PrEP) awareness, attitudes and uptake willingness among young people: gender differences and associated factors in two South African districts. Glob Health Action. 2021; 14(1):1886455. PMC: 7899653. DOI: 10.1080/16549716.2021.1886455. View